These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24356619)

  • 1. A critical review of the analytical approaches for circulating tumor biomarker kinetics during treatment.
    Almufti R; Wilbaux M; Oza A; Henin E; Freyer G; Tod M; Colomban O; You B
    Ann Oncol; 2014 Jan; 25(1):41-56. PubMed ID: 24356619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells in prostate cancer: beyond enumeration.
    Chen JF; Lu YT; Cheng S; Tseng HR; Figlin RA; Posadas EM
    Clin Adv Hematol Oncol; 2017 Jan; 15(1):63-73. PubMed ID: 28212371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
    Sumanasuriya S; Omlin A; Armstrong A; Attard G; Chi KN; Bevan CL; Shibakawa A; IJzerman MJ; De Laere B; Lolkema M; Lorente D; Luo J; Mehra N; Olmos D; Scher H; Soule H; Stoecklein NH; Terstappen LWMM; Waugh D; de Bono JS
    Eur Urol Oncol; 2018 Jun; 1(2):151-159. PubMed ID: 31100240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
    Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
    BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating Tumor Cells: A Reliable Biomarker for Prostate Cancer Treatment Assessment?
    Ciccarese C; Montironi R; Fiorentino M; Martignoni G; Brunelli M; Iacovelli R; Lopez-Beltran A; Cheng L; Scarpelli M; Moch H; Tortora G; Massari F
    Curr Drug Metab; 2017; 18(8):692-699. PubMed ID: 28524006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.
    Gorin MA; Verdone JE; van der Toom E; Bivalacqua TJ; Allaf ME; Pienta KJ
    Nat Rev Urol; 2017 Feb; 14(2):90-97. PubMed ID: 27872478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in prostate cancer - Current clinical utility and future perspectives.
    Kretschmer A; Tilki D
    Crit Rev Oncol Hematol; 2017 Dec; 120():180-193. PubMed ID: 29198331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization and clinical utility of circulating tumor cells in the treatment of prostate cancer.
    Lorente D; Mateo J; de Bono JS
    Am Soc Clin Oncol Educ Book; 2014; ():e197-203. PubMed ID: 24857103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer.
    Chen J; Cao S; Situ B; Zhong J; Hu Y; Li S; Huang J; Xu J; Wu S; Lin J; Zhao Q; Cai Z; Zheng L; Wang Q
    J Exp Clin Cancer Res; 2018 Jun; 37(1):127. PubMed ID: 29954422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Novel Association of Circulating Tumor Cells and Circulating Megakaryocytes with Prostate Cancer Prognosis.
    Xu L; Mao X; Guo T; Chan PY; Shaw G; Hines J; Stankiewicz E; Wang Y; Oliver RTD; Ahmad AS; Berney D; Shamash J; Lu YJ
    Clin Cancer Res; 2017 Sep; 23(17):5112-5122. PubMed ID: 28615267
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance.
    Liu RSC; Olkhov-Mitsel E; Jeyapala R; Zhao F; Commisso K; Klotz L; Loblaw A; Liu SK; Vesprini D; Fleshner NE; Bapat B
    J Urol; 2018 Jun; 199(6):1475-1481. PubMed ID: 29246734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer.
    Amato RJ; Melnikova V; Zhang Y; Liu W; Saxena S; Shah PK; Jensen BT; Torres KE; Davis DW
    Urology; 2013 Jun; 81(6):1303-7. PubMed ID: 23622774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
    Miyamoto DT; Lee RJ
    Urol Oncol; 2016 Nov; 34(11):490-501. PubMed ID: 27771279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
    Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
    Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
    Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
    Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD117⁺ cells in the circulation are predictive of advanced prostate cancer.
    Kerr BA; Miocinovic R; Smith AK; West XZ; Watts KE; Alzayed AW; Klink JC; Mir MC; Sturey T; Hansel DE; Heston WD; Stephenson AJ; Klein EA; Byzova TV
    Oncotarget; 2015 Jan; 6(3):1889-97. PubMed ID: 25595903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.
    Doyen J; Alix-Panabières C; Hofman P; Parks SK; Chamorey E; Naman H; Hannoun-Lévi JM
    Crit Rev Oncol Hematol; 2012 Mar; 81(3):241-56. PubMed ID: 21680196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers in prostate cancer management. Is there something new?
    Carrion DM; Gómez Rivas J; Álvarez-Maestro M; Martínez-Piñeiro L
    Arch Esp Urol; 2019 Mar; 72(2):105-115. PubMed ID: 30855011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel prognostic markers in the serum of patients with castration-resistant prostate cancer derived from quantitative analysis of the pten conditional knockout mouse proteome.
    Kälin M; Cima I; Schiess R; Fankhauser N; Powles T; Wild P; Templeton A; Cerny T; Aebersold R; Krek W; Gillessen S
    Eur Urol; 2011 Dec; 60(6):1235-43. PubMed ID: 21741162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells.
    Williams ES; Rodriguez-Bravo V; Chippada-Venkata U; De Ia Iglesia-Vicente J; Gong Y; Galsky M; Oh W; Cordon-Cardo C; Domingo-Domenech J
    J Vis Exp; 2015 Oct; (105):53182. PubMed ID: 26555435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.